Real-world Study of Dedifferentiated Liposarcoma Patients in China
NCT06115681 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 1390
Last updated 2025-07-10
Summary
This study will characterize patients with dedifferentiated liposarcoma (DDLPS) in China, including an understanding of demographic, and clinical characteristics as well as treatment patterns and clinical outcomes associated with the current real-world treatment.
Conditions
- Dedifferentiated Liposarcoma
Sponsors & Collaborators
- lead INDUSTRY
Eligibility
- Min Age
- 18 Years
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2024-03-13
- Primary Completion
- 2024-05-15
- Completion
- 2024-05-15
Countries
- China
Study Locations
More Related Trials
-
Study for the Clinical Roadmap and Prognosis of Pulmonary Artery Sarcoma.
NCT06165718 ·Status: RECRUITING
-
A Real-world Study to Explore Recurrence/Metastases of the NSCLC Patients and the Impact Factors of Patient Survivals
NCT03710616 ·Status: UNKNOWN
-
Biomarkers for Diagnosis of Lung Cancer
NCT02050100 ·Status: COMPLETED
-
Circulating and Molecular Markers Involved in the Processes of Cachexia, Anorexia and Sarcopenia in Patients With NSCLC
NCT06808113 ·Status: ACTIVE_NOT_RECRUITING
-
Predictive Models of Treatment Responses and Survival Outcomes in Patients With Soft Tissue Sarcoma
NCT05171413 ·Status: UNKNOWN
-
Treatment Patterns, Clinical Outcomes, and Healthcare Resource Utilization Associated With Chinese Patients With Advanced Lung Cancer
NCT03505515 ·Status: COMPLETED
-
MRD-guided Prognosis Prediction and Adjuvant Treatment Based on CTC and ctDNA in NSCLC
NCT06198868 ·Status: RECRUITING
-
Deep Learning Signature for Predicting Occult Nodal Metastasis of Clinical N0 Lung Cancer
NCT05425134 ·Status: UNKNOWN
-
A Retrospective Cohort Analysis of SMARCA4-Deficient Lung Cancer
NCT07121387 ·Status: COMPLETED
-
Targeted Anti-CEA CAR-T Immunotherapy for Advanced Lung Cancer
NCT06992583 ·Status: RECRUITING ·Phase: PHASE1
-
Characteristics, Treatment Patterns and Outcomes for Patients With Surgically Resected Lung Cancers
NCT06255197 ·Status: RECRUITING
-
Prospective Study for Prognostic Biomarkers of Nasopharyngeal Carcinoma
NCT03025854 ·Status: UNKNOWN
-
Clinical Study on Chimeric Antigen Receptor T Lymphocyte (CAR-T) Targeting CEA for the Treatment of CEA - Positive Advanced Lung Cancer
NCT06945523 ·Status: RECRUITING ·Phase: PHASE1
-
Therapeutic ResistAnce and Clonal Evolution Assessed With Liquid Biopsy of NSCLC Patients in China
NCT03059641 ·Status: COMPLETED
-
An Observational Study to Explore Clinical Characteristics of the Patients With T1 Non-small Cell Lung Cancer
NCT03413956 ·Status: COMPLETED
-
A Study of Molecular Residual, Dynamic Monitoring and Recurrence of Stage III Driver Mutated NSCLC
NCT06443684 ·Status: RECRUITING
-
A Study of Real-world Treatment Patterns and Outcomes in Chinese Advanced NSCLC Patients Who Previously Received at Least 2 Line Treatments
NCT06617390 ·Status: COMPLETED
-
The Use of Molecular Radiogenomics in Non-small Cell Lung Cancer
NCT05541744 ·Status: RECRUITING
-
A Radiomic Model for Risk of Local Recurrence and DFS for T3 and T4 Non-small Cell Lung Cancer
NCT06405815 ·Status: COMPLETED
-
Developing Circulating and Imaging Biomarkers Towards Personalised Radiotherapy in Lung Cancer
NCT06086574 ·Status: RECRUITING
-
Development of Innovative Preclinical Ex Vivo Models for the Study of Sarcomas and Metastases From Solid Tumors
NCT07112989 ·Status: RECRUITING
-
Autologous CIK Cells Infusion for the Treatment of Lung Cancer: a Randomized Controlled Study
NCT01498055 ·Status: UNKNOWN
-
Quantitative Evaluation of the Impact of Relaxing Eligibility Criteria for Lung Cancer Based on Real-world Data
NCT06314542 ·Status: RECRUITING
-
Analysis of Brain Metastasis in Patients With Lung Cancer
NCT00071344 ·Status: COMPLETED
-
Stereotactic Margins in Localized Bronchial Cancer (T1/T2a, N0)
NCT05605236 ·Status: COMPLETED